TNF Pharmaceuticals (NASDAQ:TNFA) Trading 0.8% Higher – What’s Next?

TNF Pharmaceuticals, Inc. (NASDAQ:TNFA) shares shot up 0.8% during trading on Thursday . The stock traded as high as $4.15 and last traded at $3.83. 459,933 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 32,220,806 shares. The stock had previously closed at $3.80.

TNF Pharmaceuticals Price Performance

The stock has a 50 day moving average of $3.73 and a two-hundred day moving average of $4.09. The stock has a market capitalization of $7.07 million, a PE ratio of -0.02 and a beta of 2.04.

TNF Pharmaceuticals Company Profile

TNF Pharmaceuticals, Inc operates as a clinical stage pharmaceutical company. It focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms. Its MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. The MYMD-1 is being developed to delay aging, increase longevity, and treat autoimmune diseases.